Pacific Edge shares edge up
The S&P/NZX 50 Index decreased 8.59 points, or 0.1%, to 11,230.55. Turnover was $126 million.
Hobson Wealth investment adviser Brad Gordon said interest rates coming off “quite sharply” in the last week gave equity markets much-needed support.
He said the sudden interest in Pacific Edge was probably on expectations for an update on whether Medicare provider Novitas will continue using Pacific Edge’s Cxbladder tests.The cancer diagnostics rose 3.1% to 49.5 cents after rising as much as 6.3%.
The company’s result for the six months ended Sept 30 are due next week.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.
![[The Wrap] What the heck is happening at the FMA?](https://goodreturns.publit.io/file/c_fill,w_300,h_200/a6c3bc06-6401-44de-96e2-286c090e132d.jpg)
